Human trials to start for stem cell treatment for blindness


An American biotech company has just announced that it has been licensed to begin human trials of a stem cell treatment for blindness.

Advanced Cell Technology is trying to treat Stargadt's Macular Dystrophy, a disease which affects 25,000 people in the US and can leave victims blinded as children.

The World Today's Max Pearson spoke to the company's chief scientific officer, Dr Robert Lanza, about the process which is now going to be put to human trial.

Copyright © 2019 BBC. The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.